Innate Pharma SA Trade And Other Current Payables To Trade Suppliers
Innate Pharma SA (IPHA) had Trade And Other Current Payables To Trade Suppliers of EUR 7.47 million as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers · last filed 2026-04-01
- 2025-12-31: Trade And Other Current Payables To Trade Suppliers 7.47M EUR.
- 2025-06-30: Trade And Other Current Payables To Trade Suppliers 4.55M EUR.
- 2024-12-31: Trade And Other Current Payables To Trade Suppliers 7.92M EUR.
- 2024-06-30: Trade And Other Current Payables To Trade Suppliers 8.75M EUR.
| Period end | Trade And Other Current Payables To Trade Suppliers |
|---|---|
| 2025-12-31 | 7.47M EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 4.55M EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 7.92M EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 8.75M EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 8.56M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 9.87M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 13.66M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 12.92M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 14.73M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 11.18M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 20.73M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 27.94M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 28.58M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 19.97M EUR 20-F · filed 2020-04-24 |